Gastroenteropancreatic nec (gep nec)
Clinical trials for Gastroenteropancreatic nec (gep nec) explained in plain language.
Never miss a new study
Get alerted when new Gastroenteropancreatic nec (gep nec) trials appear
Sign up with your email to follow new studies for Gastroenteropancreatic nec (gep nec), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Engineered immune cells take on tough cancers in first human trial
Disease control Recruiting nowThis early-phase trial tests a new treatment called ML261 for people with advanced small cell lung cancer or certain neuroendocrine cancers that have not responded to standard treatments. ML261 is made from a patient's own immune cells, which are modified in a lab to better recog…
Matched conditions: GASTROENTEROPANCREATIC NEC (GEP NEC)
Phase 1 • Sponsor: Moonlight Bio, Inc • Aim: Disease control
Last updated Aug 27, 2026 00:00 UTC
-
New radioactive 'Smart Bomb' targets Hard-to-Treat lung cancer
Disease control Recruiting nowThis study tests a new drug that delivers radiation directly to cancer cells carrying a protein called DLL3, found in small cell lung cancer and other solid tumors. The trial enrolls 138 adults whose cancer has progressed after at least two prior treatments. The goal is to check …
Matched conditions: GASTROENTEROPANCREATIC NEC (GEP NEC)
Phase 1/2 • Sponsor: Molecular Partners AG • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC